ARTICLE

RISK FACTORS AND MANAGEMENT OF BACTERIAL MENINGITIS

04 Pages : 24-33

http://dx.doi.org/10.31703/giidr.2021(VI-II).04      10.31703/giidr.2021(VI-II).04      Published : Dec 2021

Risk Factors and Management of Bacterial Meningitis

    Meningitis is the infection of the spinal cord and brain. Bacterial meningitis is a great public health concern, especially in immunocompromised patients and children, particularly in underdeveloped counties. There are various types of bacterial meningitis (pneumococcal, meningococcal, listeria monocytogenes, neonatal, Hemophilus) having different rates of incidences and etiological agents. It occurs when bacteria get into the bloodstream from the nose, sinuses and ear. s. Infants and children are more susceptible to bacterial meningitis; similarly, alcoholics, smokers, malnutrient people, people with HIV and TB are at higher risks of this infection; all these factors must be taken into account to determine its severity. The diagnosis has critical importance and is considered one of the most urgent microbial medical emergencies. The use of vaccines is essential to eradicate this disease from the globe. This article highlights the risk factors, current diagnosis, treatment options and management plans in terms of bacterial meningitis.

    Meningitis, S. Pneumoniae, HIV, Serotype
    (1) Mahnoor Khan
    Department of Pharmacy, Faculty of Biological Sciences, Quaid-e-Azam University Islamabad, Pakistan.
    (2) Maham Jahangir
    Department of Pharmacy, Faculty of Biological Sciences, Quaid-e-Azam University Islamabad, Pakistan.
    (3) Khadija Ahmadi
    Department of Pharmacy, Faculty of Biological Sciences, Quaid-e-Azam University Islamabad, Pakistan.
  • Chanteau, S., Rose., A. M. C., Djibo, S., Nato, F., & Boisier, P. (2007). Biological diagnosis of meningococcal meningitis in the African meningitis belt: Current epidemic strategy and new perspective. Pascal.
  • Deghmane, A. E., Alonso, J. M., & Taha, M. K. (2009). Emerging drugs for acute bacterial meningitis. Expert opinion on emerging drugs. 14(3), pp. 381-93.
  • Stephens, D. S. (2007). Conquering the meningococcus. FEMS microbiology reviews., 31(1), pp. 3-14.
  • Umaru, E. T., Ludin, A. N. M., Majid, M. R., Sabri, S., Moses, C., Eneghuma, W., & Tajudeen A. N. (2013). Risk factors responsible for the spread of meningococal meningitis: a review. International Journal of Education and Research, 1(2), pp. 1-30.
  • Tacon, C. L., & Flower, O. (2012). Diagnosis and Management of Bacterial Meningitis in. Emergency Medicine International, p. 8.
  • Javid, M. H. (2019). Meningococcemia.
  • La Scolea, L. J., & Dryja, D. (1984). Quantitation of bacteria in cerebrospinal fluid and blood of children with meningitis and its diagnostic significance. J Clin Microbiol, Volume 19(2), pp. 187-190.
  • Griffiths, M. J., Mcgill, F., & Solomon, T. (2018). Management of acute meningitis. Clinical Medicine, 18(2), pp. 1641-69.
  • Olson MM, S. C. L. J. J. G. D. -1. 1. J., 1994 Jun. Ten years of prospective Clostridium difficile-associated disease surveillance and treatment at the Minneapolis VA Medical Cen.1982- 1991ter..Infect Control Hosp Epidemiol, Volume 15(6), pp. 371-81.
  • DeLong, E. F., Stackebrandt, E., Thompson, F., Lory, S. (2013). The Prokaryotes. Human Microbiology.
  • Runde, T. J., Anjum, F., & Hafner, J. W. (2021). Bacterial Meningitis. StatPearls, Issue 2nd.
  • Scheld, W. M., Koedel, U., Nathan, B., & Pfister, H. W. (2013). Pathophysiology of Bacterial Meningitis: Mechanism(s) of Neuronal Injury. The Journal of infectious diseases. Volume 2, pp. 225-233.
  • Snape, M. D., & Pollard, A. J. (2005). Meningococcal polysaccharide-protein conjugate vaccines. Lancet Infective Diseases 5(5), pp. 21-30.
  • Stephens, D. S., Greenwood, B., & Brandtzaeg, P. (2007 Jun). Epidemic meningitis, meningococcaemia, and Neisseria meningitidis. Lancet, Volume 369(9580), pp. 2196-2210
  • Brouwer, M. c., & Beek, D. V. D. (2013). Bacterial meningitis. In: E. R. e. al, ed. The Prokaryotes - Human Microbiology. s.l.:Springer-Verlag Berlin Heidelberg, pp. 401-427.
  • Tønjum, T., Nilsson, F., Bruun, J. N., & Haneberg, B. (january,1984). The early phase of meningococcal disease. NIPH annals. Volume 6, pp. 175-81.
  • Torpy, J. M., Lynm, c., & Glass, R. M. (2007). Meningitis. JAMA, 1(122), p. 297.

Cite this article

    CHICAGO : Khan, Mahnoor, Maham Jahangir, and Khadija Ahmadi. 2021. "Risk Factors and Management of Bacterial Meningitis." Global Immunological & Infectious Diseases Review, VI (II): 24-33 doi: 10.31703/giidr.2021(VI-II).04
    HARVARD : KHAN, M., JAHANGIR, M. & AHMADI, K. 2021. Risk Factors and Management of Bacterial Meningitis. Global Immunological & Infectious Diseases Review, VI, 24-33.
    MHRA : Khan, Mahnoor, Maham Jahangir, and Khadija Ahmadi. 2021. "Risk Factors and Management of Bacterial Meningitis." Global Immunological & Infectious Diseases Review, VI: 24-33
    MLA : Khan, Mahnoor, Maham Jahangir, and Khadija Ahmadi. "Risk Factors and Management of Bacterial Meningitis." Global Immunological & Infectious Diseases Review, VI.II (2021): 24-33 Print.
    OXFORD : Khan, Mahnoor, Jahangir, Maham, and Ahmadi, Khadija (2021), "Risk Factors and Management of Bacterial Meningitis", Global Immunological & Infectious Diseases Review, VI (II), 24-33
    TURABIAN : Khan, Mahnoor, Maham Jahangir, and Khadija Ahmadi. "Risk Factors and Management of Bacterial Meningitis." Global Immunological & Infectious Diseases Review VI, no. II (2021): 24-33. https://doi.org/10.31703/giidr.2021(VI-II).04